Runs of homozygosity and testicular cancer risk.
Chey LovedayA SudK LitchfieldM LevyA HolroydP BroderickZ Kote-JaraiA M DunningK MuirJ PetoR EelesD F EastonD DudakiaN OrrN Pashayannull nullnull nullA ReidR A HuddartR S HoulstonC TurnbullPublished in: Andrology (2020)
Overall, our data do not support a major role in the risk of TGCT for recessively acting alleles acting through homozygosity, as measured by RoH in outbred populations of cases and controls.